Pressmeddelande

BioStock: Emplicure’s co-founder on the company’s next step

Cision Publicerad: 12 May 2022 14:56

Since it was founded in 2014, Emplicure has transformed from being a company with potential and ambitions of going public to today having one drug candidate heading into clinical studies and a consumer product ready to premiere in June. A person who has been involved throughout the company’s journey is co-founder Thomas Lundqvist, who resigned as chairman of the board in April. BioStock spoke to Lundqvist about his new role and how he sees the company’s future.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/05/emplicures-medgrundare-om-bolagets-nasta-steg/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Emplicure

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!